Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words '5-HT2 ANTAGONIST' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 59 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Rashid, M; Watanabe, M; Nakazawa, M; Nakamura, T; Hattori, K; Nagatomo, T
      Assessment of affinity and dissociation ability of a newly synthesized 5-HT2 antagonist, AT-1015: Comparison with other 5-HT2 antagonists

      JAPANESE JOURNAL OF PHARMACOLOGY
    2. Fujio, M; Kuroita, T; Sakai, Y; Nakagawa, H; Matsumoto, Y
      N-[1-(2-phenylethyl)pyrrolidin-3-yl]-1-adamantanecarboxamides as novel 5-HT2 receptor antagonists

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    3. Frishman, WH; Grewall, P
      Serotonin and the heart

      ANNALS OF MEDICINE
    4. Horacek, J
      Novel antipsychotics and extrapyramidal side effects. Theory and reality

      PHARMACOPSYCHIATRY
    5. Kuridze, N; Czernicki, Z; Jarus-Dziedzic, K; Jurkiewicz, J; Cervos-Navarro, J
      Vasostabilising effect of Dotarizine (Ca2+-channel blocker) on cerebrovascular reactivity in rabbits

      NEUROLOGICAL RESEARCH
    6. Kihara, H; Hirose, K; Koganei, H; Sasaki, N; Yamamoto, H; Kimura, A; Nishimori, T; Shoji, M; Yoshimoto, R
      AT-1015, a novel serotonin (5-HT)(2) receptor antagonist, blocks vascular and platelet 5-HT2A receptors and prevents the laurate-induced peripheral vascular lesion in rats

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    7. Miller, CH; Fleischhacker, WW
      Managing antipsychotic-induced acute and chronic akathisia

      DRUG SAFETY
    8. Mizuno, A; Ogata, A; Kamei, T; Shibata, M; Shimamoto, T; Hayashi, Y; Nakanishi, K; Takiguchi, C; Oka, N; Inomata, N
      Synthesis and serotonin 2 (5-HT2) receptor antagonist activity of 5-aminoalkyl-substituted pyrrolo [3,2-c]azepines and related compounds

      CHEMICAL & PHARMACEUTICAL BULLETIN
    9. Tanaka, N; Goto, R; Ito, R; Hayakawa, M; Sugidachi, A; Ogawa, T; Asai, F; Fujimoto, K
      [2-(omega-phenylalkyl)phenoxyl alkylamines II: Synthesis and selective serotonin-2 receptor binding

      CHEMICAL & PHARMACEUTICAL BULLETIN
    10. Amokhtari, M; Andersen, K; Ibazizene, M; Gourand, F; Dauphin, F; Barre, L
      Synthesis of [C-11]Lu 29-066, a 5-HT2 receptor antagonist

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    11. MEADE CJ
      THE MECHANISM BY WHICH EPINASTINE STOPS AN ADENOSINE ANALOG FROM CONTRACTING BDE RAT AIRWAYS

      American journal of respiratory and critical care medicine
    12. ARNT J; SKARSFELDT T
      DO NOVEL ANTIPSYCHOTICS HAVE SIMILAR PHARMACOLOGICAL CHARACTERISTICS - A REVIEW OF THE EVIDENCE

      Neuropsychopharmacology
    13. OLAUSSON P; ERICSON M; PETERSSON A; KOSOWSKI A; SODERPALM B; ENGEL JA
      NEFAZODONE ATTENUATES THE BEHAVIORAL AND NEUROCHEMICAL EFFECTS OF ETHANOL

      Alcohol
    14. DAVIDSON JRT; WEISLER RH; MALIK ML; CONNOR KM
      TREATMENT OF POSTTRAUMATIC-STRESS-DISORDER WITH NEFAZODONE

      International clinical psychopharmacology
    15. MILLER CH; MOHR F; UMBRICHT D; WOERNER M; FLEISCHHACKER WW; LIEBERMAN JA
      THE PREVALENCE OF ACUTE EXTRAPYRAMIDAL SIGNS AND SYMPTOMS IN PATIENTSTREATED WITH CLOZAPINE, RISPERIDONE, AND CONVENTIONAL ANTIPSYCHOTICS

      The Journal of clinical psychiatry
    16. CHAIRUNGSRILERD N; FURUKAWA K; TADANO T; KISARA K; OHIZUMI Y
      EFFECT OF GAMMA-MANGOSTIN THROUGH THE INHIBITION OF 5-HYDROXY-TRYPTAMINE(2A) RECEPTORS IN 5-FLUORO-ALPHA-METHYLTRYPTAMINE-INDUCED HEAD-TWITCH RESPONSES OF MICE

      British Journal of Pharmacology
    17. MOYANOVA S; KORTENSKA L; KIROV R
      HIGH-VOLTAGE ELECTROENCEPHALOGRAM SPINDLES IN RATS, AGING AND 5-HT2 ANTAGONISM

      Brain research
    18. MISSOURIS CG; CAPPUCCIO FP; VARSAMIS E; BARRON JL; CARR E; MARKANDU ND; MACGREGOR GA
      SEROTONIN AND HEART-RATE IN HYPERTENSIVE AND NORMOTENSIVE SUBJECTS

      The American heart journal
    19. ROBERTS AJ; MCARTHUR RA; HULL EE; POST C; KOOB GF
      EFFECTS OF AMPEROZIDE, 8-OH-DPAT, AND FG-5974 ON OPERANT RESPONDING FOR ETHANOL

      Psychopharmacology
    20. ABIDARGHAM A; LARUELLE M; AGHAJANIAN GK; CHARNEY D; KRYSTAL J
      THE ROLE OF SEROTONIN IN THE PATHOPHYSIOLOGY AND TREATMENT OF SCHIZOPHRENIA

      The Journal of neuropsychiatry and clinical neurosciences
    21. CRISINEL D; BISSONNETTE B; FEIHL F; GARDAZ JP
      EFFICIENCY OF KETANSERIN IN POSTANESTHETI C SHIVERING

      Annales francaises d'anesthesie et de reanimation
    22. MOYANOVA S; KIROV R; IVANOVA V
      POWER SPECTRAL ELECTROENCEPHALOGRAM ANALYSIS OF THE EFFECTS OF RITANSERIN IN FREELY MOVING RATS DURING QUIET WAKING

      Methods and findings in experimental and clinical pharmacology
    23. FARRE M; ROSET PN; LLORENTE M; MARQUEZ M; ALBET C; PEREZ JA; HERRERO E; ORTIZ JA
      CLINICAL PHARMACOKINETICS AND TOLERABILITY OF DOTARIZINE IN HEALTHY-SUBJECTS AFTER SINGLE AND MULTIPLE ORAL-ADMINISTRATION

      Methods and findings in experimental and clinical pharmacology
    24. BUSATTO GF; KERWIN RW
      PERSPECTIVES ON THE ROLE OF SEROTONERGIC MECHANISMS IN THE PHARMACOLOGY OF SCHIZOPHRENIA

      JOURNAL OF PSYCHOPHARMACOLOGY
    25. SHAW LA; BATEY AJ; COKER SJ
      COMBINED ADMINISTRATION OF 5-HT2 AND THROMBOXANE A(2) ANTAGONISTS - EFFECTS ON PLATELET-AGGREGATION AND ISOLATED CARDIAC-MUSCLE

      British Journal of Pharmacology
    26. ARVANITIS LA; MILLER BG; BORISON RL; PITTS WM; SHARIF ZA; HAMNER MB; HERZ MI; TRUE JE; VELLIGAN D; KNESEVICH MA; SMALL J; STEINBOOK R; HERTZMAN M; KECK PE; NEWCOMER JW; GRACE J; ROTROSEN J; TANDON R; DOTT SG; FERGUSON JM; ADDINGTON DEN; MACEWAN GW; NAIR VNP; SHRIQUI CL; WILLIAMS R; DANIEL DG; SHEHI GM; PATTERSON WM; MERIDETH CH
      MULTIPLE FIXED DOSES OF SEROQUEL (QUETIAPINE) IN PATIENTS WITH ACUTE EXACERBATION OF SCHIZOPHRENIA - A COMPARISON WITH HALOPERIDOL AND PLACEBO

      Biological psychiatry
    27. GRONFIER C; LUTHRINGER R; FOLLENIUS M; SCHALTENBRAND N; MACHER JP; MUZET A; BRANDENBERGER G
      A QUANTITATIVE-EVALUATION OF THE RELATIONSHIPS BETWEEN GROWTH-HORMONESECRETION AND DELTA-WAVE ELECTROENCEPHALOGRAPHIC ACTIVITY DURING NORMAL SLEEP AND AFTER ENRICHMENT IN DELTA-WAVES

      Sleep
    28. RYDZEWSKI A; URANO T; HACHIYA T; KANEKO H; BABA S; TAKADA Y; TAKADA A
      THE EFFECT OF A 5HT(2) RECEPTOR ANTAGONIST SARPOGRELATE (MCI-9042) TREATMENT ON PLATELET-FUNCTION IN BUERGERS-DISEASE

      Thrombosis research
    29. DANILOV AB; DANILOV AB; VEIN AM
      NOCICEPTIVE FLEXOR REFLEX - THE METHOD OF INVESTIGATION OF BRAIN MECHANISMS OF PAIN CONTROL

      Zurnal nevropatologii i psihiatrii im. S.S. Korsakova
    30. ABIDARGHAM A; LARUELLE M; CHARNEY D; KRYSTAL J
      SEROTONIN AND SCHIZOPHRENIA - A REVIEW

      Medicamentos de actualidad
    31. OWENS DGC
      ADVERSE-EFFECTS OF ANTIPSYCHOTIC AGENTS - DO NEWER AGENTS OFFER ADVANTAGES

      Drugs
    32. SHAW LA; COKER SJ
      SUPPRESSION OF REPERFUSION-INDUCED ARRHYTHMIAS WITH COMBINED ADMINISTRATION OF 5-HT2 AND THROMBOXANE A(2) ANTAGONISTS

      British Journal of Pharmacology
    33. KAPUR S; REMINGTON G
      SEROTONIN-DOPAMINE INTERACTION AND ITS RELEVANCE TO SCHIZOPHRENIA

      The American journal of psychiatry
    34. PANOCKA I; CICCOCIOPPO R; POLIDORI C; ROMAGNOLI S; FROLDI R; MASSI M
      POSSIBLE MECHANISM OF ACTION FOR THE ATTENUATION OF ETHANOL INTAKE INDUCED BY RITANSERIN IN RATS

      Psychopharmacology
    35. JOHNSON BA; JASINSKI DR; GALLOWAY GP; KRANZLER H; WEINREIB R; ANTON RF; MASON BJ; BOHN MJ; PETTINATI HM; RAWSON R; CLYDE C
      RITANSERIN IN THE TREATMENT OF ALCOHOL DEPENDENCE - A MULTI CENTER CLINICAL-TRIAL

      Psychopharmacology
    36. LAZAROVA M; PETKOVA B; PETKOV VD
      EFFECT OF DOTARIZINE ON ELECTROCONVULSIVE SHOCK OR PENTYLENETETRAZOL-INDUCED AMNESIA AND ON SEIZURE REACTIVITY IN RATS

      Methods and findings in experimental and clinical pharmacology
    37. HE H; RICHARDSON JS
      A PHARMACOLOGICAL, PHARMACOKINETIC AND CLINICAL OVERVIEW OF RISPERIDONE, A NEW ANTIPSYCHOTIC THAT BLOCKS SEROTONIN 5-HT2 AND DOPAMINE D-2 RECEPTORS

      International clinical psychopharmacology
    38. CAZZOLA M; MATERA MG; DAMATO G; ROSSI F
      EFFECTS OF SEROTONIN ON AIRWAYS - RECENT DEVELOPMENTS

      Allergy
    39. COENEN AML; ATES N; SKARSFELDT T; VANLUIJTELAAR ELJM
      EFFECTS OF SERTINDOLE ON SLEEP-WAKE STATES, ELECTROENCEPHALOGRAM, BEHAVIORAL-PATTERNS, AND EPILEPTIC ACTIVITY OF RATS

      Pharmacology, biochemistry and behavior
    40. FRISHMAN WH; HUBERFELD S; OKIN S; WANG YH; KUMAR A; SHAREEF B
      SEROTONIN AND SEROTONIN ANTAGONISM IN CARDIOVASCULAR AND NON-CARDIOVASCULAR DISEASE

      Journal of clinical pharmacology
    41. SUZUKI T; MISAWA M
      SERTINDOLE ANTAGONIZES MORPHINE-INDUCED, COCAINE-INDUCED, AND METHAMPHETAMINE-INDUCED PLACE PREFERENCE IN THE RAT

      Life sciences
    42. KITAICHI K; YAMADA K; YONEDA Y; OGITA K; HASEGAWA T; FURUKAWA H; NABESHIMA T
      RISPERIDONE PREVENTS THE DEVELOPMENT OF SUPERSENSITIVITY, BUT NOT TOLERANCE, TO PHENCYCLIDINE IN RATS TREATED WITH SUBACUTE PHENCYCLIDINE

      Life sciences
    43. BENINGTON JH; HELLER HC
      MONOAMINERGIC AND CHOLINERGIC MODULATION OF REM-SLEEP TIMING IN RATS

      Brain research
    44. HOWARD HR; SHENK KD; SMOLAREK TA; MARX MH; WINDELS JH; ROTH RW
      SYNTHESIS OF H-3-LABELED AND C-14-LABELED CP-88,059 - A POTENT ATYPICAL ANTIPSYCHOTIC AGENT

      Journal of labelled compounds & radiopharmaceuticals
    45. SEYLER DE; MURPHYFARMER CM
      CHRONIC TOXICITY STUDY WITH THE SEROTONIN ANTAGONIST AMESERGIDE ADMINISTERED NASOGASTRICALLY TO RHESUS-MONKEYS FOR ONE-YEAR

      Drug development research
    46. HSIEH CP; SAKAI K; BRUNS GC; DAGE RC
      EFFECTS OF MDL-28,133A, A 5-HT2-RECEPTOR ANTAGONIST, ON PLATELET-AGGREGATION AND CORONARY-THROMBOSIS IN DOGS

      Journal of cardiovascular pharmacology
    47. HSIEH CP; SAKAI K; BRUNS GC; DAGE RC
      EFFECTS OF MDL-28,133A, A 5-HT2-RECEPTOR ANTAGONIST, ON PLATELET-AGGREGATION AND CORONARY-THROMBOSIS IN DOGS

      Journal of cardiovascular pharmacology
    48. OHNO Y; ISHIDA K; IKEDA K; ISHIBASHI T; OKADA K; NAKAMURA M
      EVALUATION OF BRADYKINESIA INDUCTION BY SM-9018, A NOVEL 5-HT2 AND D-2 RECEPTOR ANTAGONIST, USING THE MOUSE POLE TEST

      Pharmacology, biochemistry and behavior
    49. HEIM C; SIEKLUCKA M; SONTAG KH
      LEVEMOPAMIL INJECTION AFTER CEREBRAL OLIGEMIA REDUCES SPATIAL MEMORY DEFICITS IN RATS

      Pharmacology, biochemistry and behavior
    50. KANAMORI A; MATOBA K; YAJIMA Y
      EFFECTS OF SARPOGRELATE ON SEROTONIN-INDUCED INCREASES IN CYTOSOLIC CA2+ IN CULTURED RAT MESANGIAL CELLS

      Life sciences
    51. BJORK A; CHRISTENSSON E; ALBINSSON A; GUSTAFSSON B; PETTERSSON E; PETTERSSON G; SVARTENGREN J; ANDERSSON G
      IN THE SEARCH FOR A NOVEL CLASS OF ANTIPSYCHOTIC-DRUGS - PRECLINICAL PHARMACOLOGY OF FG5803, A 1-PIPERAZINECARBOXAMIDE DERIVATIVE

      The Journal of pharmacology and experimental therapeutics
    52. ANDERSSON G; LARSSON K
      EFFECTS OF FG-5893, A NEW COMPOUND WITH 5-HT1A RECEPTOR AGONISTIC AND5-HT2 RECEPTOR ANTAGONISTIC PROPERTIES, ON MALE-RAT SEXUAL-BEHAVIOR

      European journal of pharmacology
    53. BAN H; KATO H; ARAKI T; FUJIKURA H; HASEGAWA Y; KOGURE K
      EFFECTS OF NAFTIDROFURYL OXALATE, A 5-HT2 ANTAGONIST, ON NEUROTRANSMISSION AND TRANSDUCTION SYSTEMS IN THE GERBIL HIPPOCAMPUS

      Brain research
    54. FUJIKURA H; KATO H; ARAKI T; BAN H; HASEGAWA Y; KOGURE K
      EFFECTS OF NAFTIDROFURYL OXALATE, A 5-HT2 ANTAGONIST, ON NEURONAL DAMAGE AND LOCAL CEREBRAL BLOOD-FLOW FOLLOWING TRANSIENT CEREBRAL-ISCHEMIA IN GERBILS

      Brain research
    55. WIESEL FA; NORDSTROM AL; FARDE L; ERIKSSON B
      AN OPEN CLINICAL AND BIOCHEMICAL-STUDY OF RITANSERIN IN ACUTE PATIENTS WITH SCHIZOPHRENIA

      Psychopharmacology
    56. VANBEIJSTERVELDT LEC; GEERTS RJF; LEYSEN JE; MEGENS AAHP; VANDENEYNDE HMJ; MEULDERMANS WEG; HEYKANTS JJP
      REGIONAL BRAIN DISTRIBUTION OF RISPERIDONE AND ITS ACTIVE METABOLITE 9-HYDROXY-RISPERIDONE IN THE RAT

      Psychopharmacology
    57. PANOCKA I; CICCOCIOPPO R; POLIDORI C; MASSI M
      THE NUCLEUS-ACCUMBENS IS A SITE OF ACTION FOR THE INHIBITORY EFFECT OF RITANSERIN ON ETHANOL INTAKE IN RATS

      Pharmacology, biochemistry and behavior
    58. PREHN JHM; WELSCH M; BACKHAUSS C; NUGLISCH J; AUSMEIER F; KARKOUTLY C; KRIEGLSTEIN J
      EFFECTS OF SEROTONERGIC DRUGS IN EXPERIMENTAL BRAIN ISCHEMIA - EVIDENCE FOR A PROTECTIVE ROLE OF SEROTONIN IN CEREBRAL-ISCHEMIA

      Brain research
    59. JORIS J; BANACHE M; BONNET F; SESSLER DI; LAMY M
      CLONIDINE AND KETANSERIN BOTH ARE EFFECTIVE TREATMENT FOR POSTANESTHETIC SHIVERING

      Anesthesiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 11:29:58